| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:1832-1841.)
© 2008 American Heart Association, Inc.
Imaging |
From the Department of Cardiology and Institute of Postgraduate Medical Education and Research, Northwick Park Hospital, Harrow, UK.
Correspondence to Professor Roxy Senior, MBBS, MD, DM, FRCP, FESC, FACC, Consultant Cardiologist and Director of Cardiac Research, Honorary Professor, Middlesex University London, Honorary Senior Lecturer, Imperial College, London, Department of Cardiology, Northwick Park Hospital, Harrow HA1 3UJ, UK. E-mail roxysenior{at}cardiac-research.org
Received February 22, 2007; accepted January 22, 2008.
| Abstract |
|---|
|
|
|---|
Methods and Results— Sixty-three symptomatic LBBB patients (group A), 10 left ventricular ejection fraction–matched control subjects without LBBB and no CAD (group B), and 10 normal control subjects (group C) underwent resting echocardiography. Rest and vasodilator MCE and SPECT were undertaken in LBBB patients. Septal (SW) and posterior wall (PW) thickness, thickening, quantitative myocardial blood flow (MBF), and MBF reserve were measured. SW/PW thickness and percentage thickening ratios were lower (P<0.01 and P<0.05, respectively) in group A compared with both groups B and C, but resting SW/PW MBF and MBF reserve ratios were similar in all 3 groups. MBF reserve but not MBF was reduced in groups A and B (2.2±0.7 versus 2.2±0.2; P=0.98) compared with group C (3.1±0.5; P<0.01). SW thickness was an independent predictor (P=0.006) of SPECT perfusion defects in LBBB patients without CAD. MCE (92%) had a sensitivity similar to SPECT (92%); however, the specificity of MCE (95%) was superior (P<0.0001) to SPECT (47%) for the detection of CAD.
Conclusions— Despite asymmetrical reduction in SW thickness and function, MBF is preserved and MBF reserve is homogeneously reduced in LBBB patients with left ventricular systolic dysfunction. Because of partial volume effects, the accuracy of SPECT for detecting CAD was significantly compromised compared with MCE in this patient cohort.
Key Words: bundle-branch block coronary disease echocardiography nuclear medicine perfusion
| Introduction |
|---|
|
|
|---|
Clinical Perspective p 1841
Quantitative myocardial contrast echocardiography (MCE), which uses contrast agents that are entirely intravascular, has been shown in experimental models and humans to be accurate in assessing myocardial perfusion both at rest and during stress.11–13 The aims of the study were to investigate the effects of LBBB on myocardial structure, function, and perfusion with MCE; to ascertain the value of MCE for the detection of CAD in LBBB patients; and to test the hypothesis that the partial volume effects caused by septal thinning and impaired thickening rather than true hypoperfusion are responsible for SPECT perfusion defects in patients without CAD.
| Methods |
|---|
|
|
|---|
The study complied with the Declaration of Helsinki. All patients gave written informed consent to the study protocol, which was approved by the Institutional Review Board of Northwick Park Hospital.
Study Design
LBBB was established by a standard 12-lead ECG before study recruitment and was confirmed by repeat 12-lead ECG on the study day. All patients underwent transthoracic 2-dimensional echocardiography, MCE, SPECT, and coronary arteriography. Stress MCE and SPECT were performed on the same day.
ECG
LBBB was defined as QRS duration
120 ms, the presence of notched R waves in the lateral precordial leads (V5 and V6) and leads I and aVL, small or absent initial r waves in the right precordial leads (V1 and V2) followed by deep S waves, absent septal q waves in left-sided leads, and a prolonged intrinsicoid deflection (>60 ms) in V5 and V6.
Two-Dimensional Echocardiography
Two-dimensional echocardiography was performed in standard apical and parasternal views with tissue harmonic imaging (SONOS 7500, Philips Medical Systems, Best, the Netherlands). LVEF, LV end-diastolic volume, and LV end-systolic volume were measured with Simpsons apical biplane rule.14 End diastole was identified by the onset of the QRS complex; end systole was defined as the smallest LV diameter. Tracing of the LV contour excluded the papillary muscles and trabeculations within the LV cavity as recommended by the American Society of Echocardiography.14 Regional wall thickness (WT) for the septal wall (SW) and posterior wall (PW) was measured at 3 points in the cardiac cycle (end diastole, midsystole [midpoint between the onset of QRS and end systole], and end systole) from the parasternal long-axis 2-dimensional view; maximum WT was assessed; and a mean value was obtained. A narrow sector was used to maximize frame rate (65 to 75 Hz). Percentage of SW and PW thickening were calculated using the following formula: ([maximal WT–end-diastolic WT]x100)/end-diastolic WT. Ratios of SWT to PWT and percentage thickening also were calculated.
MCE Studies
MCE was performed with SonoVue (Bracco Research SA, Geneva, Switzerland) at rest in the 3 apical views (apical 4-chamber, 2-chamber, and 3-chamber views) using low-power MCE (power modulation technique) at a mechanical index of 0.1. Background gains were set so that minimal tissue signal was seen. The color gains were then adjusted so that no Doppler signal was seen except at the mitral valve and proximal to the apex. SonoVue was infused at 50 to 70 mL/h with VueJect (BR-INF 100, Bracco Research SA), an infusion syringe pump that rotates gently throughout infusion to maintain microbubble suspension. The infusion rate was adjusted to obtain the best possible myocardial opacification with minimal attenuation. Once optimized, the machine settings were kept constant throughout the study. The focus was set at the mitral valve level but moved toward the apex if there was concern about a near-field artifact. Nonstandard apical views (eg, bringing the lateral wall into the sector field) were used, if required, to attempt to overcome basal attenuation artifacts. Flash echocardiography at a high mechanical index (1.0) was performed to achieve myocardial microbubble destruction, after which 15 consecutive end-systolic frames were digitally captured in each view (3 sequences in each) at a low mechanical index (0.1). Imaging was repeated at peak hyperemia after administration of 0.56 mg/kg dipyridamole.
Normal myocardial perfusion at rest was considered to be present when all segments (16-segment model) showed homogeneous contrast opacification within 5 seconds after destructive imaging. A reversible perfusion defect was considered present when a contrast defect was observed 1 second after destructive imaging after vasodilator stress with the presence of a transmural defect filling from the subepicardium to subendocardium during subsequent cardiac cycles.15 CAD was considered to be present when 2 contiguous segments demonstrated perfusion defects (rest or stress). Multivessel disease was considered present when perfusion defects were noted in >1 vascular territory. The analysis was performed by an investigator (R.S.) who was blinded to clinical, coronary arteriographic, and SPECT data.
Quantitative MCE
Quantitative MCE was performed offline by a single observer (S.H.) unaware of the 2-dimensional echocardiographic or angiographic data. Standard commercial software (Q-Laboratory, Philips Medical Systems) was used to quantify myocardial replenishment for 15 frames after bubble destruction by placing the region of interest across the entire thickness of the myocardium, excluding the high-intensity endocardial and epicardial borders.2 The basal segments of the 16-segment LV model were not included in the quantitative analysis. QLab software automatically constructed background-subtracted plots of peak myocardial contrast intensity, representing myocardial blood volume (A), versus pulsing intervals, from which the slope of the replenishment curve depicting mean microbubble velocity (β) was derived. Frames showing wide variation in contrast intensity were discarded to minimize errors in the analysis. Myocardial blood volume was subsequently normalized for blood pool videointensity by placing the ventricular cavity region of interest adjacent to the myocardial region of interest using a previously validated equation: normalized A=10([A–blood pool]/10)x100.13 SW and PW myocardial blood flow (MBF) and MBF reserve (MBFR) were calculated from these formulas: MBF=Axβ and MBFR=stress MBF/resting MBF. Ratios of SW to PW MBF and MBFR also were calculated.
Gated Technetium-99m Sestamibi SPECT
A separate-day stress-rest protocol was used. A rest study was performed on a separate day 60 to 90 minutes after injection of 600 MBq technetium-99m sestamibi. For stress imaging, 600 MBq technetium-99m sestamibi was injected at peak hyperemia after administration of dipyridamole (during stress MCE). Images were acquired 60 to 90 minutes after injection with a multihead camera with high-resolution collimators. The camera energy window (20%) was set on the 140-keV photopeak of technetium-99m sestamibi. Particular care was taken to avoid patient motion and overlap from extracardiac activity. A total of 32 projections (each lasting 40 seconds) were acquired over a 180° arc from the 45° right anterior oblique to the 45° left posterior positions. Both rest and stress tomograms were reconstructed in the vertical and horizontal long- and short-axis planes and were simultaneously analyzed with a standard 16-segment LV model. SPECT perfusion was graded with a well-validated scoring system: 0=normal tracer uptake, 1=mildly reduced tracer uptake, 2=moderately reduced tracer uptake, 3= severely reduced tracer uptake, and 4=absent tracer uptake.16
A rest defect was defined as a score of
2 in at least 1 segment (matching 16-segment LV model). A fixed defect was any resting defect that remained unchanged during stress with an accompanying wall thickening abnormality on gated SPECT. A reversible defect was defined as a reduction in tracer uptake by at least 1 grade except when the resting score was 0 when the change in score should be >2. CAD was considered present when a resting defect and/or a reversible defect were detected in
2 contiguous segments. SPECT myocardial quantification was performed with MyoQuant software.17 The software calculates and quantifies perfusion and perfusion deficits in myocardial SPECT data through the analysis of polar maps generated from the radial slices. Normalized perfusion values were displayed in the 16-segment grid model. The qualitative and quantitative assessments of SPECT data were performed by 2 independent observers (A.J. and C.K.) who were blinded to clinical, MCE, and coronary arteriographic data.
Coronary Arteriography
Selective coronary arteriography was performed, and patients with CAD were defined as those demonstrating
50% luminal diameter stenosis of any major epicardial artery or major branch. Multivessel disease was defined as CAD in the left anterior descending artery and right coronary artery or left circumflex artery.
Statistical Analysis
Results from normally distributed continuous data are expressed as mean±SD. Categorical variables are presented as percentages. The paired t test was used to compare the differences within groups, and the independent t test was used to compare continuous variables between groups. One-way ANOVA was used with post hoc Tukey adjustment in the multiple comparisons between different groups of continuous variables to minimize the type I error. We used
2 tests to compare categorical variables between groups. A receiver-operating characteristics curve was plotted to determine the best MBF reserve cutoff value for predicting significant CAD. One-way ANOVA was used to compare the MCE variables among various grades of stenosis. The presence of abnormality in either of the coronary territories was considered to be positive for the detection of CAD on a per-patient basis.
The effect of various parameters for the prediction of SPECT perfusion defect was obtained by logistic regression analysis. Subsequently, the joint effects of the explanatory factors on the SPECT perfusion defect were examined together in a multivariate analysis. Only factors with values of P<0.1 in the univariable analysis were included in the multivariable analysis. A backwards selection procedure was used to determine the final model. McNemars test was used to compare the sensitivity and specificity of MCE and SPECT. A value of P<0.05 (2 sided) was considered significant. Statistical analysis was performed with Analyze-it software for Microsoft Excel (version 1.62, Analyze-it Software Ltd, Leeds, UK) and SPSS version 14.0 (SPSS Inc, Chicago, Ill).
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
|
|
Correlates of Myocardial Structure in LBBB
The ratio of SWT to PWT was significantly lower in group A (LBBB and no CAD) compared with groups B (LVEF-matched control subjects without LBBB and no CAD) and C (normal control subjects), whereas no differences were noted between groups B and C (Table 3). This was because SWT in group A was significantly lower than in both groups B and C.
|
Correlates of Myocardial Function in LBBB
The ratio of percentage of SW to PW thickening was significantly lower in patients with LBBB (group A) compared with groups B and C, whereas no differences were noted between groups B and C (Table 3). The primary reason for the reduced ratio of SW to PW thickening in group A was that SW thickening was lower compared with group B despite similar reductions in LVEF and comparable LV volumes. Both groups A and B showed significant reductions in percentage SW and PW thickening compared with normal control subjects (Group C).
Correlates of Myocardial Perfusion in LBBB
Although LBBB patients demonstrated smaller SWT and percentage wall thickening compared with groups B and C, there were no significant differences in indexes of MBF (Table 3). Resting A, β, and MBF were similar across all 3 groups, as were the ratios of SW to PW MBF (1.01±0.14, 0.99±0.15, and 1.02±0.15, respectively). Similarly, no significant differences were noted in patients with LBBB with and without CAD for A (P=0.53) and MBF (P=0.49), but β tended to be lower in the CAD group (P=0.07). Resting MBF was not reduced in patients with LBBB (group A) compared with LVEF-matched control subjects without LBBB (group B) and normal control subjects (group C). Similarly, the ratios of SW to PW MBFR were similar in all 3 groups. However, MBFR was reduced equally in groups A and B (2.2±0.7 versus 2.2±0.2; P=0.98) compared with normal control subjects (3.1±0.5; P<0.0005; Figure 1).
|
Comparison of LBBB Patients With and Without CAD
No significant differences were noted in LBBB patients with and without CAD for SWT (P=0.60), PWT (P=0.51), and ratio of SWT to PWT (P=0.37). Similarly, there were no significant differences for percentage of SW thickening (P=0.56), percentage of PW thickening (P=0.17), and ratio of SW to PW thickening (P=0.49). However, in the LBBB group with CAD, MBFR (0.78±0.46) was significantly reduced compared with LBBB patients without CAD (P<0.0001).
Distribution of Perfusion Defects
Of the 38 patients without CAD, 20 (53%) demonstrated perfusion abnormalities on SPECT, 18 of which (90%) were septal. The majority of perfusion defects were fixed. MCE demonstrated normal perfusion in all these patients; however, MCE demonstrated perfusion abnormalities in 2 patients (5%) with normal SPECT perfusion. The distribution of perfusion abnormalities by the 2 techniques is illustrated in Figure 2.
|
Relation Between Regional WT, Function, and Indexes of MBF in Patients With and Without SPECT Perfusion Defects
Quantitative SPECT analysis revealed that the ratio of SW to PW count was significantly reduced (P=0.01) in patients with visual SPECT perfusion defects (0.79±0.06) compared with those without SPECT defects (0.85±0.07). Furthermore, perfusion defects were significantly (P=0.009) larger in the septum in patients with visual perfusion defects (26±8%) compared with those without (18±11%). The qualitative tracer uptake score in patients with perfusion defects was 2.5±0.27, with 97% of the defects classified as moderate to severe. Mean SWT, end-diastolic SWT, SW thickening, and LVEF were significantly lower in patients with septal SPECT perfusion defects compared with those without such defects (Table 4). Mean SWT was significantly lower than mean PWT (1.15±0.12 and 1.28±0.13 cm, respectively; P<0.0001) in patients with SPECT perfusion defects. However, there was no difference between mean SWT and mean PWT in patients with normal SPECT perfusion (1.35±0.20 and 1.35±0.21 cm, respectively; P=0.92). On multivariable analysis, mean SWT emerged as the only independent predictor (P=0.006) of false SPECT perfusion defects. The end-diastolic WT cutoff of 1.02 cm provided a sensitivity of 80% and specificity of 83% (area under the curve, 0.88; Figure 3). Figure 4 shows an example of a patient with normal coronary arteriography who had a normal MCE study but whose SPECT revealed significant fixed perfusion defects in the septum and apex.
|
|
|
Diagnostic Accuracy of Quantitative MCE for the Detection of CAD
Sensitivity and specificity for the detection of CAD (
50% luminal diameter stenosis) for 63 anterior and 62 posterior (failure to intubate right coronary artery in 1 patient) coronary territories by quantitative MCE were determined by plotting a receiver-operating characteristics curve (Figure 5). The area under the curve was higher for the detection of CAD in the anterior circulation (0.95) compared with posterior circulation (0.88). An MBFR cutoff of 0.85 provided a sensitivity of 89%, specificity of 91%, positive predictive value of 80%, and negative predictive value of 95% for anterior circulation; those values for posterior circulation were 79%, 84%, 68%, and 90% and on a per-patient basis were 80%, 79%, 71% and 86%, respectively. MBFR was significantly higher in patients with coronary artery stenosis
50% stenosis compared with patients with >50% stenosis (2.00±0.77 versus 0.78±0.46; P<0.0001; Figure 6). Among patients with CAD, MBFR also was able to differentiate between differing grades of coronary artery stenosis (Figure 7).
|
|
|
Diagnostic Accuracy of Qualitative MCE for the Detection of CAD: Comparison With Qualitative SPECT
Of the 25 patients with CAD, both qualitative MCE and qualitative SPECT detected CAD in 23 patients (92%). However, of the 38 patients with no CAD, MCE correctly predicted the absence of CAD in 36 patients (95%) and SPECT in 18 patients (47%; P<0.0001). The positive predictive values of MCE and SPECT were 92% and 54% and the negative predictive values were 95% and 90%, respectively, for the prediction of CAD. MCE was more accurate than SPECT for the detection of CAD (94% versus 65%; P=0.0003). At the vascular territory level, MCE correctly localized left anterior descending artery disease in 16 of 18 (89%) compared with SPECT, which detected 13 of 18 (72%) (P=NS). The specificities of MCE and SPECT in this territory were 90% and 45% (P<0.001). Localization of right coronary artery/left circumflex artery disease was similar between MCE and SPECT (sensitivity, 72% versus 68%, P=NS; specificity, 80% versus 75%, P=NS). MCE was abnormal in all 12 patients (100%) with multivessel disease and correctly detected 11 of 12 patients (92%) with multivessel disease. The corresponding numbers for SPECT were 83% and 58%. The number of segments demonstrating reversible defects in patients with CAD was significantly (P=0.008) greater with MCE (6.8±3.0) compared with SPECT (4.4±3.7). If only reversible defects were considered to represent CAD, then the sensitivity of MCE on a vascular territory basis was 84%, but the sensitivity of SPECT dropped to 57% (P=0.03).
| Discussion |
|---|
|
|
|---|
Partial volume effects are of particular relevance in myocardial SPECT studies because of the limited spatial resolution of gamma cameras (10 to 12 mm). Our study showed that an end-diastolic SWT of <10 mm produced a perfusion defect in 80% of patients. Furthermore, during SPECT image acquisition, systolic thickening and diastolic relaxation of the myocardium result in continuous changes in the recovery coefficient because the myocardial counts actually measured depend considerably on systolic thickening. Myocardial thickening leads to a higher recovery coefficient and subsequently to greater myocardial counts. In our study, mean systolic SWT was the only independent factor accounting for perfusion defects in the septum among other confounding variables.
Experimental models in which right ventricular pacing was used to mimic LBBB demonstrated similar asymmetrical reduction in SWT and function. Several investigators found that during right ventricular pacing, regional shortening of the septum, which is activated early, is reduced compared with the PW, which is activated late.9,18 It is likely that as a result of this asynchronous activation of the left ventricle, redistribution of mechanical load occurs in the left ventricle, so mechanical load is least in the early activated SW.18 This probably results in an adaptive reduction in wall thickness and function of the septum. However, resting myocardial blood volume and perfusion are preserved despite a reduction in WT and function. Preservation of septal myocardial perfusion in patients with LBBB also was shown in recent positron emission tomography studies using 150– water and 13N-NH3, which are robust markers of MBF, as blood flow tracers.19,20 In addition, our study demonstrated that MBFR is reduced, although homogeneously, throughout the LV. These findings support the hypothesis that asymmetrical reductions in SWT and function with preserved myocardial perfusion occur as a physiological response to a regional decrease in myocardial load. Symmetrical reduction in MBFR probably resulted from underlying cardiomyopathy in the absence of CAD.
Clinical Implications
Cardiac resynchronization therapy is now a recognized management strategy in heart failure and LBBB. One of the underlying mechanisms of the success of cardiac resynchronization therapy is that it likely restores synchronous activation, allowing more homogeneous distribution of mechanical load throughout the LV and thus reversing septal dysfunction. In our study, in which no patients had prior acute myocardial infarction, myocardial viability was maintained as predicted by preserved myocardial blood volume and MBF. However, myocardial blood velocity, which reflects MBF, tended to be lower in patients with CAD compared with those without CAD, which is consistent with hibernating myocardium.21 The presence of myocardial viability has been shown to be one of the important predictors of success after cardiac resynchronization therapy.22
We also demonstrated that despite changes in regional myocardial structure and function, MCE was able to detect CAD accurately. The reason is that MCE has excellent spatial (2 to 4 mm) and temporal resolution.12,13,15 MBFR was markedly reduced in patients with LBBB and CAD compared with those without LBBB and CAD. MCE could exclude nearly all patients (>90%) without CAD and detected all patients with multivessel disease. We also have shown that as a result of partial volume effects, the specificity of SPECT for detecting CAD was significantly reduced compared with MCE. Our study, similar to other studies, found SPECT to have lower accuracy for predicting CAD in patients with LBBB because of a high percentage of false-positive anteroseptal and septal perfusion defects.3–7 This also was shown in a smaller study comparing MCE and SPECT.23 No difference in sensitivity between the 2 techniques was noted for the detection of CAD. However, because reversible defects (suggesting myocardial ischemia) occurred in only 57% of CAD patients, a significant proportion of patients undergoing SPECT would inadvertently be denied revascularization. The low incidence of reversibility in patients with CAD is due to a low tracer count (partial volume effect) at rest and thus an indiscernible reduction in tracer uptake during stress because at least a 20% to 30% change in myocardial blood volume is required to produce a perfusion defect. On the other hand, because MCE does not suffer from partial volume effects and because it tracks blood flow, unlike SPECT, it demonstrated reversible perfusion defects in
85% of patients with CAD. Furthermore, the reversible defects were larger compared with SPECT in patients with CAD.
Comparison With Other Competing Techniques
Stress echocardiography also has reduced accuracy for detecting CAD in patients with LBBB because it relies on changes in regional wall thickening and motion, both of which are affected even in LBBB without CAD.24 Because MCE assesses myocardial perfusion, it is a function-independent technique and thus is unlikely to be affected by the unique functional effects of LBBB. This is reflected in the excellent diagnostic accuracy of MCE for the detection of CAD in our study. Another emerging noninvasive technique that can reliably assess CAD is multislice computed tomography.25 However, assessment of symptomatic patients with LBBB not only requires demonstration of CAD but also must include assessment of its functional significance and evaluation of the presence or absence of myocardial viability. Echocardiography with MCE has the advantage in that it can provide a comprehensive assessment of cardiac structure, cardiac function, presence or absence of flow-limiting CAD, and status of myocardial viability in a single examination in patients presenting with symptomatic LBBB.
Study Limitations
Most patients with LBBB in the present study demonstrated LV systolic dysfunction; thus, the conclusions drawn from the present study pertain largely to this specific population. In our study population, shortness of breath was the predominant symptom that may explain the low mean LVEF. Presence of LV dysfunction also explains the lower MBFR in this group compared with normal control subjects; MBFR was further reduced in LBBB patients with CAD. Thus, our results do not apply to patients with LBBB and normal LV systolic function. However, in a smaller study of asymptomatic LBBB patients who demonstrated predominantly normal LV function, the performance of MCE and SPECT for the detection of CAD was similar to our study.23
The control group in our study was small, and multiple comparisons were performed, which may have led to a false-positive result. To minimize the possibility of type I error rate, we performed a 1-way ANOVA with post hoc adjustment for multiple comparisons with the Tukey method. In our study, factors that may affect cardiac structure, function, and perfusion are represented reasonably in the study versus control groups. The main variables likely to affect cardiac structure are age, hypertension, diabetes mellitus, and gender. In the 3 groups, age, hypertension, and diabetes mellitus were well represented. Furthermore, any discrepancy was minimized by measurement of the ratios of the SWT to PWT. The latter specifically negates any bias that may have occurred with the discrepant gender distribution in the 3 groups. The main demographic factors that may affect function and perfusion include age, hypertension, diabetes mellitus, hyperlipidemia, and smoking history; most of these factors are not discrepantly distributed. To further negate any possible errors when categorical variables are compared between relatively small groups, we assessed Framingham risk score, which incorporates all the above variables into a continuous variable. Framingham risk scores were similar across all 3 groups.
Finally, for normal control subjects, we have included patients presenting with chest pain but with normal cardiac enzymes and normal resting and stress function, which classifies them as having a low probability of significant cardiac disease. However, cardiac disease cannot be entirely excluded in this group.
Conclusions
Despite a reduction in SWT and function compared with the PW, myocardial perfusion at rest is preserved and homogeneous in patients with LBBB without CAD and LV systolic dysfunction. However, MBFR is reduced, albeit homogeneously. Because MCE is a partial volume– and function-independent technique, the accuracy of MCE for detecting CAD is not compromised compared with SPECT.
| Acknowledgments |
|---|
This study was funded by a grant from the Cardiac Research Fund, Institute of Postgraduate Medical Education and Research, Harrow, Middlesex, UK.
Disclosures
None.
| References |
|---|
|
|
|---|
2. Eriksson P, Wilhelmsen L, Rosengren A. Bundle-branch block in middle-aged men: risk of complications and death over 28 years. Eur Heart J. 2005; 26: 2300–2306.
3. Tandogan I, Yetkin E, Ileri M, Ortapamuk H, Yanik A, Cehreli S, Duru E. Diagnosis of coronary artery disease with Tl-201 SPECT in patients with left bundle branch block: importance of alternative interpretation approaches for left anterior descending coronary lesions. Angiology. 2001; 52: 103–108.[Medline] [Order article via Infotrieve]
4. Hirzel HO, Senn M, Nuesch K, Buettner C, Pfeiffer A, Hess OM, Krayenbuehl HP. Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol. 1984; 53: 764–769.[CrossRef][Medline] [Order article via Infotrieve]
5. Larcos G, Gibbons RJ, Brown ML. Diagnostic accuracy of exercise thallium-201 single-photon emission computed tomography in patients with left bundle branch block. Am J Cardiol. 1991; 68: 756–760.[CrossRef][Medline] [Order article via Infotrieve]
6. Vaduganathan P, He ZX, Raghavan C, Mahmarian JJ, Verani MS. Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging? J Am Coll Cardiol. 1996; 28: 543–550.[Abstract]
7. Matzer L, Kiat H, Friedman JD Van Train K, Maddahi J, Berman DS. A new approach to the assessment of tomographic thallium-201 scintigraphy in patients with left bundle branch block. J Am Coll Cardiol. 1991; 17: 1309–1317.[Abstract]
8. Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block: the effect of interventricular asynchrony. Circulation. 1989; 79: 845–853.
9. Prinzen FW, Cheriex EC, Delhaas T, van Ooosterhout MF, Arts T, Wellens HJ, Reneman RS. Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: a study in dogs with ventricular pacing and in patients with left bundle branch block. Am Heart J. 1995; 130: 1045–1053.[CrossRef][Medline] [Order article via Infotrieve]
10. Ono S, Nohara R, Kambara H, Okuda K, Kawai C. Regional myocardial perfusion and glucose metabolism in experimental left bundle branch block. Circulation. 1992; 85: 1125–1131.
11. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998; 97: 473–483.
12. Senior R, Janardhanan R, Jeetley P, Burden L. Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure. Circulation. 2005; 112: 1587–1593.
13. Peltier M, Vancraeynest D, Pasquet A, Ay T, Roelants V, Dhondt AM, Melin JA, Vanoverschelde JL. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography: comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J Am Coll Cardiol. 2004; 43: 257–264.
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgessell H, Reicheck N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989; 2: 358–367.[Medline] [Order article via Infotrieve]
15. Senior R, Lepper W, Pasquet A, Chung G, Hoffman R, Vanoverschelde JL, Cerqueira M, Kaul S. Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. Am Heart J. 2004; 147: 1100–1105.[CrossRef][Medline] [Order article via Infotrieve]
16. Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol. 2002; 9: 454–462.[CrossRef][Medline] [Order article via Infotrieve]
17. Vivegnis BTD, Foulon J, Rigo P. Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity. Eur J Nucl Med. 1996; 23: 1603–1612.[CrossRef][Medline] [Order article via Infotrieve]
18. Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol. 1990; 259: H300–H308.[Medline] [Order article via Infotrieve]
19. Nowak B, Stellbrink C, Schaefer WM, Sinha AM, Breithardt OA, Kaiser HJ, Reinartz P, Hanrath P, Buell U. Comparison of regional myocardial blood flow and perfusion in dilated cardiomyopathy and left bundle branch block: role of wall thickening. J Nucl Med. 2004; 45: 414–418.
20. Zanco P, Desideri A, Mobilia G, Cargnel S, Milan E, Celegon L, Buchberger R, Ferlin G. Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses. J Nucl Med. 2000; 41: 973–977.
21. Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng ASH, Petersen SE, Searle N, Channon KM, Banning AP, Neubauer S. Resting myocardial blood flow is impaired in hibernating myocardium. Circulation. 2005; 112: 3289–3296.
22. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Bax JJ. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007; 28: 33–41.
23. Karavidas AI, Matsakas EP, Lazaros GA, Brestas PS, Avramidis DA, Vacharoulis AA, Fotiadis IN, Lprres DA, Zacharoulis AA. Comparison of myocardial contrast echocardiography with SPECT in the evaluation of coronary artery disease in asymptomatic patients with LBBB. Int J Cardiol. 2006; 112: 334–340.[CrossRef][Medline] [Order article via Infotrieve]
24. Geleinse ML, Vigna C, Kasprzak JD, Rambaldi R, Salvatori MP, Elhendy A, Cornel JH, Fioretti PM, Roelandt JR. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block: a multicentre study. Eur Heart J. 2000; 21: 1666–1673.
25. Ghostine S, Caussin C, Daoud B, Habis M, Perrier E, Pesenti-Rossi D, Sigal-Cinqualbre A, Angel CY, Lancelin B, Capderou A, Paul JF. Non-invasive detection of coronary artery disease in patients with left bundle branch block using 64 slice computed tomography. J Am Coll Cardiol. 2006; 48: 1925–1934.
Related Article:
This article has been cited by other articles:
CLINICAL PERSPECTIVE
The present study is the first to simultaneously assess cardiac structure, function, perfusion, and perfusion reserve using quantitative myocardial contrast echocardiography in patients with symptomatic left bundle-branch block who predominantly had left ventricular dysfunction. In these patients, regardless of coronary artery disease (CAD), there were asymmetrical reductions in septal wall thickness and function compared with the posterior wall; however, resting myocardial blood volume and flow were homogeneously preserved. Single-photon emission computed tomography (SPECT) is widely used for the detection and risk stratification of CAD. However, we demonstrated that because of asymmetrical reductions in septal thickness and function, SPECT has a significantly higher incidence of false-positive perfusion defects resulting from partial volume effects as a consequence of its poorer spatial and temporal resolution compared with myocardial contrast echocardiography. Despite no difference in sensitivity between the 2 techniques for the detection of CAD, because of partial volume effects, reversible defects (suggesting myocardial ischemia) occurred in only 57% of CAD patients with SPECT imaging compared with 92% with myocardial contrast echocardiography. This finding has both cost and safety implications in that patients would be inappropriately referred for coronary arteriography after SPECT and a significant proportion of patients undergoing SPECT would inadvertently be denied revascularization. Compared with other imaging techniques such as multislice computed tomography, SPECT, or stress echocardiography, myocardial contrast echocardiography has the advantage of providing an accurate comprehensive assessment of cardiac structure and function and denoting the presence or absence of flow-limiting CAD and the status of myocardial viability in a single examination in patients presenting with symptomatic left bundle-branch block.
Circulation 2008 117: 1769.
![]() |
R Mizuno, S Fujimoto, Y Saito, and S Nakamura Depressed recovery of subendocardial perfusion in persistent heart failure after complete revascularisation in diabetic patients with hibernating myocardium Heart, May 1, 2009; 95(10): 830 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Senior, H. Becher, M. Monaghan, L. Agati, J. Zamorano, J. L. Vanoverschelde, and P. Nihoyannopoulos Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography Eur J Echocardiogr, March 1, 2009; 10(2): 194 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Senior, M. Monaghan, M. L. Main, J. L. Zamorano, K. Tiemann, L. Agati, N. J. Weissman, A. L. Klein, T. H. Marwick, M. Ahmad, et al. Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging Eur J Echocardiogr, January 1, 2009; 10(1): 26 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaul Myocardial Contrast Echocardiography: A 25-Year Retrospective Circulation, July 15, 2008; 118(3): 291 - 308. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |